Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reassessing the risk of natalizumab-associated PML.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
BRIEF: Teva files for Copaxone-Laquinimod patent
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Dimethylfumarate induces apoptosis in human mast cells.
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Development of Guillain-Barré syndrome in a patient with multiple sclerosis during treatment with glatiramer acetate.
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
New data reinforce efficacy of TECFIDERA® (dimethyl fumarate) in MS patients with high disease activity
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Recent insights into the mechanism of action of glatiramer acetate.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
A monoclonal natural human IgM protects axons in the absence of remyelination.
Optimal combination of FLAIR and T2-weighted MRI for improved lesion contrast in multiple sclerosis.
Biogen slips as FDA extends review of MS drug

Pages